πŸ‡ΊπŸ‡Έ FDA
Patent

US 6204360

Retro-inverso thymosin alpha 1 hybrids

expired A61KA61K38/00

Quick answer

US patent 6204360 (Retro-inverso thymosin alpha 1 hybrids) held by USA Universe Bioengineering, Inc. expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
USA Universe Bioengineering, Inc.
Grant date
Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/00